Cardiovascular Systems CSII
$ 20.0
0.15%
Quarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Balance Sheet 2011-2024 | CSII
Annual Balance Sheet Cardiovascular Systems
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-64.6 M | -68.9 M | - | -53.3 M | -95.2 M | -86.8 M | -60.6 M | -83.8 M | -124 M | -55.3 M | -18 M | -9.02 M |
Long Term Debt |
1.33 M | 1.72 M | - | - | - | - | - | - | - | 7.47 M | 12.8 M | 8.33 M |
Long Term Debt Current |
526 K | 487 K | - | - | - | - | - | - | 2.4 M | 5.1 M | 4.68 M | - |
Total Non Current Liabilities |
- | - | - | 28.3 M | 31.4 M | 34.6 M | 6.01 M | 2 M | 117 K | 7.65 M | 13.1 M | 9.94 M |
Total Current Liabilities |
40 M | 54.6 M | 44.5 M | 42.3 M | 37.5 M | 41 M | 35.5 M | 29.9 M | 29.7 M | 22.4 M | 17.9 M | - |
Total Liabilities |
73.2 M | 81.6 M | 70.7 M | 70.6 M | 68.9 M | 75.6 M | 41.5 M | 31.9 M | 29.8 M | 30.1 M | 30.9 M | 25.1 M |
Deferred Revenue |
2.11 M | 2.4 M | 1.87 M | 1.76 M | 1.24 M | - | - | - | 59 K | 156 K | - | - |
Retained Earnings |
-424 M | -381 M | -363 M | -330 M | -328 M | -329 M | -327 M | -271 M | -239 M | -203 M | -179 M | -162 M |
Total Assets |
323 M | 353 M | 340 M | 219 M | 203 M | 194 M | 142 M | 171 M | 182 M | 96.9 M | 63.1 M | 46.8 M |
Cash and Cash Equivalents |
66.4 M | 71.1 M | 185 M | 74.2 M | 116 M | 108 M | 60.6 M | 83.8 M | 127 M | 67.9 M | 35.5 M | 21.2 M |
Book Value |
249 M | 271 M | 269 M | 148 M | 134 M | 118 M | 101 M | 139 M | 152 M | 66.8 M | 32.2 M | 21.6 M |
Total Shareholders Equity |
249 M | 271 M | 269 M | 148 M | 134 M | 118 M | 101 M | 139 M | 152 M | 66.8 M | 32.2 M | 21.6 M |
All numbers in USD currency
Quarterly Balance Sheet Cardiovascular Systems
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.11 M | 1.22 M | 1.33 M | 1.43 M | 1.52 M | 1.64 M | 1.72 M | 1.72 M | 1.94 M | 2.05 M | 15 K | 57 K | 175 K | 306 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 5.74 M | 7.47 M | 7.47 M | 10.4 M | 11.6 M | 12.8 M | 12.8 M | 15.4 M | 8.44 M | 8.33 M | 8.33 M |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 117 K | 112 K | 123 K | 5.9 M | 7.65 M | 7.65 M | 10.6 M | 11.8 M | 13.1 M | 13.1 M | 15.8 M | 9.86 M | 9.94 M | 9.94 M |
Total Liabilities |
72.1 M | 69.9 M | 73.2 M | 70.5 M | 66.9 M | 69.1 M | 81.6 M | 81.6 M | 75.1 M | 73.3 M | 70.7 M | 76.9 M | 80.9 M | 75 M | 70.6 M | 70.6 M | 68.6 M | 66.3 M | 68.9 M | 68.9 M | 66.1 M | 70.3 M | 75.6 M | 75.6 M | 46.6 M | 35.4 M | 41.5 M | 41.5 M | 30 M | 31.8 M | 31.9 M | 31.9 M | 32.5 M | 33.9 M | 29.8 M | 29.8 M | 24.9 M | 29.8 M | 30.1 M | 30.1 M | 27.5 M | 31.1 M | 30.9 M | 30.9 M | 30.1 M | 25 M | 25.1 M | 25.1 M |
Deferred Revenue |
525 K | 694 K | 2.11 M | 2.81 M | 2.72 M | 2.49 M | 2.4 M | 2.4 M | 2.08 M | 2.09 M | 1.87 M | 1.76 M | 1.66 M | 1.71 M | 1.76 M | 1.76 M | 1.52 M | 1.25 M | 1.24 M | 1.24 M | 1.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-443 M | -436 M | -424 M | -414 M | -404 M | -395 M | -381 M | -381 M | -369 M | -369 M | -363 M | -348 M | -345 M | -341 M | -330 M | -330 M | -331 M | -331 M | -328 M | -331 M | -332 M | -331 M | -329 M | -329 M | -328 M | -329 M | -327 M | -327 M | -300 M | -285 M | -271 M | -271 M | -252 M | -247 M | -239 M | -239 M | -219 M | -211 M | -203 M | -203 M | -190 M | -184 M | -179 M | -179 M | -170 M | -166 M | -162 M | -162 M |
Total Assets |
312 M | 312 M | 323 M | 324 M | 326 M | 332 M | 353 M | 353 M | 349 M | 342 M | 340 M | 220 M | 224 M | 217 M | 219 M | 219 M | 207 M | 200 M | 203 M | 203 M | 190 M | 190 M | 194 M | 194 M | 159 M | 138 M | 142 M | 142 M | 151 M | 162 M | 171 M | 171 M | 181 M | 182 M | 182 M | 182 M | 181 M | 95.1 M | 96.9 M | 96.9 M | 56.6 M | 60.1 M | 63.1 M | 63.1 M | 52 M | 48.3 M | 46.8 M | 46.8 M |
Cash and Cash Equivalents |
59.8 M | 62.8 M | 66.4 M | 67 M | 65.9 M | 66.9 M | 71.1 M | 71.1 M | 73.8 M | 92.7 M | 73.8 M | 69.6 M | 65.5 M | 58.9 M | 65.5 M | 58.9 M | 119 M | 113 M | 119 M | 113 M | 107 M | 105 M | 107 M | 105 M | 79.3 M | 58.2 M | 79.3 M | 58.2 M | 62.2 M | 76.7 M | 65.3 M | 76.7 M | 101 M | 116 M | 101 M | 116 M | 147 M | 63.2 M | 147 M | 63.2 M | 29.2 M | 32.2 M | 29.2 M | 32.2 M | 24.6 M | 22.7 M | 24.6 M | 22.7 M |
Book Value |
239 M | 242 M | 249 M | 253 M | 260 M | 263 M | 271 M | 271 M | 274 M | 268 M | 269 M | 143 M | 143 M | 142 M | 148 M | 148 M | 139 M | 134 M | 134 M | 134 M | 124 M | 120 M | 118 M | 118 M | 112 M | 103 M | 101 M | 101 M | 121 M | 131 M | 139 M | 139 M | 148 M | 148 M | 152 M | 152 M | 156 M | 65.3 M | 66.8 M | 66.8 M | 29.2 M | 29 M | 32.2 M | 32.2 M | 21.9 M | 23.3 M | 21.6 M | 21.6 M |
Total Shareholders Equity |
239 M | 242 M | 249 M | 253 M | 260 M | 263 M | 271 M | 263 M | 274 M | 268 M | 274 M | 143 M | 143 M | 143 M | 143 M | 142 M | 139 M | 139 M | 139 M | 134 M | 124 M | 120 M | 124 M | 120 M | 112 M | 103 M | 101 M | 101 M | 121 M | 131 M | 139 M | 139 M | 148 M | 148 M | 152 M | 152 M | 156 M | 65.3 M | 66.8 M | 66.8 M | 29.2 M | 29 M | 32.2 M | 32.2 M | 21.9 M | 23.3 M | 21.6 M | 21.6 M |
All numbers in USD currency